2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-(propan-2-yl)acetamide
Chemical Structure Depiction of
2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-(propan-2-yl)acetamide
2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-(propan-2-yl)acetamide
Compound characteristics
Compound ID: | G640-0888 |
Compound Name: | 2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-(propan-2-yl)acetamide |
Molecular Weight: | 441.57 |
Molecular Formula: | C19 H27 N3 O5 S2 |
Smiles: | CC1CSc2ccc(cc2N(CC(NC(C)C)=O)C1=O)S(N1CCOCC1)(=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 1.5821 |
logD: | 1.5821 |
logSw: | -2.6787 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 79.009 |
InChI Key: | XUVDHAFQIBFDTC-CQSZACIVSA-N |